Total Payments
$1,039
2022 Payments
$402.53
Companies
17
Transactions
53
Medicare Patients
2,119
Medicare Billing
$230,397
Payment Breakdown by Category
Food & Beverage$1,039 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,039 | 53 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $244.09 | 12 | $0 (2022) |
| Corcept Therapeutics | $139.34 | 7 | $0 (2022) |
| Biogen, Inc. | $124.04 | 6 | $0 (2022) |
| IBSA Pharma Inc. | $116.47 | 6 | $0 (2022) |
| Novo Nordisk Inc | $73.49 | 4 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $58.72 | 3 | $0 (2021) |
| GENZYME CORPORATION | $50.88 | 2 | $0 (2020) |
| Biohaven Pharmaceutical Holding Company Ltd. | $33.93 | 2 | $0 (2022) |
| Amgen Inc. | $31.99 | 2 | $0 (2022) |
| Collegium Pharmaceutical, Inc. | $30.06 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $402.53 | 20 | Biogen, Inc. ($104.42) |
| 2021 | $350.80 | 18 | Lilly USA, LLC ($146.46) |
| 2020 | $271.36 | 14 | Corcept Therapeutics ($79.63) |
| 2017 | $14.43 | 1 | Smith & Nephew, Inc. ($14.43) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2022 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $17.06 | General |
| Category: Endocrinology | ||||||
| 08/09/2022 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Neurology | ||||||
| 07/14/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: PRIMARY CARE | ||||||
| 06/28/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Diabetes | ||||||
| 06/09/2022 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $21.16 | General |
| Category: Endocrinology | ||||||
| 06/02/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: DIABETES | ||||||
| 05/23/2022 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Neuroscience | ||||||
| 05/09/2022 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Neurology | ||||||
| 04/22/2022 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $20.90 | General |
| 04/04/2022 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Neurology | ||||||
| 03/30/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Neuroscience | ||||||
| 03/28/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: PRIMARY CARE | ||||||
| 03/17/2022 | Avion Pharmaceuticals | Dhivy (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Parkinson's disease | ||||||
| 02/28/2022 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $23.27 | General |
| Category: Endocrinology | ||||||
| 02/21/2022 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Neurology | ||||||
| 02/17/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Diabetes | ||||||
| 02/08/2022 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Endocrinology | ||||||
| 01/27/2022 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $17.28 | General |
| Category: Endocrinology | ||||||
| 01/18/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Endocrinology | ||||||
| 01/10/2022 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Neurology | ||||||
| 12/21/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: PRIMARY CARE | ||||||
| 12/07/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Diabetes | ||||||
| 12/06/2021 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Endocrinology | ||||||
| 12/03/2021 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: NEUROLOGY | ||||||
| 11/30/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 12 | 625 | 1,048 | $204,806 | $55,590 |
| 2021 | 13 | 785 | 1,653 | $329,755 | $104,286 |
| 2020 | 9 | 709 | 1,305 | $216,375 | $70,521 |
Total Patients
2,119
Total Services
4,006
Medicare Billing
$230,397
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 221 | 418 | $86,108 | $25,152 | 29.2% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 161 | 285 | $36,480 | $9,083 | 24.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 107 | 107 | $32,742 | $8,267 | 25.2% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2022 | 11 | 50 | $11,250 | $3,981 | 35.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 45 | $13,680 | $3,596 | 26.3% |
| 11750 | Permanent removal fingernail or toenail | Office | 2022 | 12 | 14 | $9,016 | $1,748 | 19.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $7,456 | $1,589 | 21.3% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2022 | 14 | 17 | $2,873 | $976.48 | 34.0% |
| 11730 | Simple separation of fingernail or toenail from nail bed, first nail | Office | 2022 | 11 | 11 | $3,124 | $655.01 | 21.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 15 | $1,875 | $500.29 | 26.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 12 | 44 | $176.00 | $40.76 | 23.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 12 | 26 | $26.00 | $2.46 | 9.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 241 | 583 | $114,698 | $38,562 | 33.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 81 | 190 | $55,309 | $18,665 | 33.7% |
| 11721 | Removal of tissue from 6 or more finger or toe nails | Office | 2021 | 182 | 407 | $49,816 | $13,895 | 27.9% |
| 11042 | Removal of skin and tissue first 20 sq cm or less | Office | 2021 | 27 | 119 | $36,902 | $12,008 | 32.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 117 | 117 | $34,376 | $9,368 | 27.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 39 | 39 | $17,523 | $4,583 | 26.2% |
| 97597 | Removal of tissue from wounds per session, first 20 sq cms or less | Office | 2021 | 13 | 49 | $11,025 | $4,000 | 36.3% |
| 11056 | Removal of 2 to 4 thickened skin growths | Office | 2021 | 12 | 17 | $2,797 | $1,044 | 37.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 22 | 24 | $2,846 | $1,035 | 36.4% |
| 11730 | Separation of single nail plate from nail bed | Office | 2021 | 11 | 12 | $3,253 | $859.89 | 26.4% |
| 11720 | Removal of tissue from 1 to 5 finger or toe nails | Office | 2021 | 11 | 12 | $976.00 | $215.04 | 22.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 13 | 50 | $200.00 | $48.96 | 24.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 16 | 34 | $34.00 | $3.75 | 11.0% |
About Dr. Judith Olkaba, DPM
Dr. Judith Olkaba, DPM is a Podiatrist healthcare provider based in Dumfries, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2008. The National Provider Identifier (NPI) number assigned to this provider is 1891952875.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Judith Olkaba, DPM has received a total of $1,039 in payments from pharmaceutical and medical device companies, with $402.53 received in 2022. These payments were reported across 53 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,039).
As a Medicare-enrolled provider, Olkaba has provided services to 2,119 Medicare beneficiaries, totaling 4,006 services with total Medicare billing of $230,397. Data is available for 3 years (2020–2022), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Podiatrist
- Other Specialties Foot Surgery
- Location Dumfries, VA
- Active Since 05/19/2008
- Last Updated 11/07/2023
- Taxonomy Code 213E00000X
- Entity Type Individual
- NPI Number 1891952875
Products in Payments
- Korlym (Drug) $139.34
- TYSABRI (Biological) $124.04
- Tirosint (Drug) $116.47
- TRULICITY (Drug) $100.62
- NURTEC ODT (Drug) $92.65
- DUPIXENT (Biological) $78.48
- Ozempic (Drug) $73.49
- BAQSIMI (Drug) $63.67
- Aimovig (Biological) $31.99
- XTAMPZA (Drug) $30.06
- JARDIANCE (Drug) $23.60
- EMGALITY (Drug) $22.60
- Dexcom G6 Transmitter (Medical Supply) $20.99
- LYUMJEV (Drug) $20.48
- MOUNJARO (Drug) $18.98
- Dhivy (Drug) $14.83
- Hat-Trick (Device) $14.43
- Vimpat (Drug) $13.76
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.